Peter Batesko

Precision Orthopedics & Sports Medicine serves Maryland and Washington, DC, with 14 offices and 18 providers.

Precision Orthopedics & Sports Medicine serves Maryland and Washington, DC, with 14 offices and 18 providers.

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

Care Equity Capital Management, L.P. is an investment management company based out of New York, NY, United States.

Precision Orthopedics & Sports Medicine serves Maryland and Washington, DC, with 14 offices and 18 providers.

Precision Orthopedics & Sports Medicine serves Maryland and Washington, DC, with 14 offices and 18 providers.

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

Founded in 1978, Clayton, Dubilier & Rice (CD&R) is an investment firm with an investment strategy predicated on building stronger, more profitable businesses. We work collaboratively with corporate and family business sellers on transactions to maximize value. We believe many corporations, CEOs and entrepreneurs select CD&R as their partner because of our reputation for trustworthiness and operational leadership. We practice investing as a craft, relying on a dedicated and cohesive team with a shared sense of purpose and values. Our investment approach blends skilled investment judgment with extensive experience driving growth and operating excellence.